Alcon (ALC) Debt Ratio (2009 - 2026)

Alcon (ALC) posted Debt Ratio of 0.13 for Q2 2026, up 1.46% on a QoQ basis from 0.13 in Q1 2026, and down 8.23% year-over-year from 0.15 in Q2 2025.

Analysis

Alcon (ALC) Debt Ratio (2009 - 2026) Analysis & Trends

Alcon has reported Debt Ratio for 11 years, with the latest figure at 0.13 in Q2 2026.

On a quarterly basis, Debt Ratio fell 8.23% year-over-year to 0.13 in Q2 2026; TTM through Jun 2026 was 0.13, a 8.23% decrease from a year earlier, with the FY2025 full-year figure at 0.13, down 11.8% from the prior year.
Debt Ratio was 0.13 for Q2 2026 at Alcon, up from 0.13 in the prior quarter.
The five-year high for Debt Ratio was 0.16 in Q4 2023, with the low at 0.0 in Q1 2024.
Average Debt Ratio over 5 years is 0.08, with a median of 0.13 recorded in 2025.
The sharpest annual moves came in 2022 and 2023: Debt Ratio slumped 102.41% in 2022, then surged 5443.84% in 2023.
Over 5 years, Debt Ratio stood at 0.0 in 2022, then jumped by 4793.72% to 0.16 in 2023, then dropped by 4.21% to 0.15 in 2024, then decreased by 11.8% to 0.13 in 2025, then advanced by 1.13% to 0.13 in 2026.
The last three Debt Ratio figures came in at 0.13 (Q2 2026), 0.13 (Q1 2026), and 0.13 (Q4 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	180.55 Bn	174.95 Bn	7.27 Bn	0.30
2	Intuitive Surgical	128.01 Bn	122.80 Bn	1.96 Bn	-
3	Medtronic	117.17 Bn	108.35 Bn	6.34 Bn	0.30
4	Stryker	104.15 Bn	100.67 Bn	4.50 Bn	0.31
5	Boston Scientific	63.37 Bn	62.83 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.75 Bn	45.50 Bn	1.35 Bn	0.04
7	Alcon	33.01 Bn	31.55 Bn	1.68 Bn	0.13
8	Dexcom	32.16 Bn	30.22 Bn	830.00 Mn	-
9	Steris	20.74 Bn	20.25 Bn	684.20 Mn	0.20
10	Zimmer Biomet Holdings	17.65 Bn	17.24 Bn	1.54 Bn	0.33

Historic Data

Download Data